Published in Ann Oncol on November 09, 2005
Tumor angiogenesis: insights and innovations. J Oncol (2010) 1.04
Low lipoprotein(a) concentration is associated with cancer and all-cause deaths: a population-based cohort study (the JMS cohort study). PLoS One (2012) 0.89
Angiogenesis in cancer: Anti-VEGF escape mechanisms. Transl Lung Cancer Res (2012) 0.87
Potential therapeutic target for malignant paragangliomas: ATP synthase on the surface of paraganglioma cells. Am J Cancer Res (2015) 0.83
Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model. Transl Oncol (2014) 0.78
Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors B20-4.1.1 and angiostatin (K1-3). PLoS One (2014) 0.76
A monoclonal antibody (Mc178-Ab) targeted to the ecto-ATP synthase β-subunit-induced cell apoptosis via a mechanism involving the MAPKase and Akt pathways. Clin Exp Med (2011) 0.76
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47
The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) (1971) 4.65
How stable is stable? Function versus community composition. Appl Environ Microbiol (1999) 3.08
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A (2001) 2.77
The status of women at one academic medical center. Breaking through the glass ceiling. JAMA (1990) 2.47
Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff. Mol Cell Biol (2000) 2.41
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Prevalence of urinary tract infection in febrile infants. J Pediatr (1993) 2.12
A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst (1984) 2.08
A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage (2004) 2.05
Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem (1998) 2.05
Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature. Mol Cell Biol (2000) 1.95
Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. Lung Cancer (2006) 1.77
Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis (2000) 1.73
Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch Surg (1990) 1.64
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. J Immunol (1981) 1.58
Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine (Baltimore) (1978) 1.57
Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst (1980) 1.49
Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli. J Natl Cancer Inst (1995) 1.47
Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans (1997) 1.45
Parent comprehension of polio vaccine information pamphlets. Pediatrics (1996) 1.44
Rabbit muscle L-glycerol-3-phosphate dehydrogenase. Substrate activity of 3,4-dihydroxybutyl 1-phosphonate and 4-hydroxy-3-oxobutyl 1-phosphonate. Biochim Biophys Acta (1974) 1.44
An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis (1988) 1.43
Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med (1987) 1.42
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm (1997) 1.40
Delayed recognition of podophyllum toxicity in a patient receiving epidural morphine. Anesth Analg (1990) 1.40
Ifosfamide-induced hyperpigmentation. Cancer (1993) 1.38
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology (2002) 1.35
Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med (1984) 1.32
Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys (2000) 1.32
Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer (1980) 1.31
Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology (2009) 1.30
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet (2009) 1.28
Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway. Pharmacogenomics J (2004) 1.27
Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists. J Immunol (1984) 1.25
Early understanding of mental entities: a reexamination of childhood realism. Child Dev (1986) 1.24
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J Immunol (2000) 1.23
The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry (1996) 1.17
Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev (1982) 1.15
A dominant positive and negative selectable gene for use in mammalian cells. Proc Natl Acad Sci U S A (1991) 1.13
Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. Kidney Int (1986) 1.12
Mechanisms of depressed reactivity to dinitrochlorobenzene and ultraviolet-induced tumors during ultraviolet carcinogenesis in BALB/c mice. Cell Immunol (1978) 1.09
Security of infant-mother, -father, and -metapelet attachments among kibbutz-reared Israeli children. Monogr Soc Res Child Dev (1985) 1.08
Role of natural killer cells in host defense against cancer metastasis. Symp Fundam Cancer Res (1983) 1.08
Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. J Immunol (1983) 1.06
Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice. Cancer Res (1981) 1.06
Sexual transmission of human papillomaviruses in heterosexual and male homosexual couples, studied by DNA hybridisation. Genitourin Med (1988) 1.05
Central registry for venous air embolism. Anesth Analg (1995) 1.05
"Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. Biotechnology (N Y) (1992) 1.04
Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum (1997) 1.04
Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma. J Immunol (1986) 1.04
Effects of prostaglandins and cAMP levels on monocyte IL-1 production. Agents Actions (1989) 1.03
Positive regulatory elements (HF-1a and HF-1b) and a novel negative regulatory element (HF-3) mediate ventricular muscle-specific expression of myosin light-chain 2-luciferase fusion genes in transgenic mice. Mol Cell Biol (1994) 1.03
Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. J Pharmacol Exp Ther (2005) 1.03
Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma. Cancer Treat Res (2007) 1.03
Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression. Arthritis Rheum (1986) 1.02
The role of natural killer cells in the control of tumor growth and metastasis. Biochim Biophys Acta (1985) 1.02
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer. Ann Oncol (2007) 1.02
Regulation of a human cardiac actin gene introduced into rat L6 myoblasts suggests a defect in their myogenic program. Mol Cell Biol (1986) 1.01
Comparison of three methods for quantitating respiratory response to hypoxia in man. Respir Physiol (1972) 1.01
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Antimicrob Agents Chemother (1997) 1.01
CD3-associated heterodimeric polypeptides on suppressor hybridomas define biologically active inhibitory cells. Proc Natl Acad Sci U S A (1988) 1.00
Helicase inhibition by anthracycline anticancer agents. Mol Pharmacol (1992) 1.00
SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid. Biochem Pharmacol (1987) 0.99
Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus (2006) 0.99
Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein. Immunology (1975) 0.98
Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells. Immunology (1978) 0.98
The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet (2011) 0.98
A 17S multiprotein form of murine cell DNA polymerase mediates polyomavirus DNA replication in vitro. J Cell Biochem (1994) 0.97
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol (2013) 0.97
Structural requirements for in vivo and in vitro immunogenicity in hapten-specific delayed hypersensitivity. Cell Immunol (1973) 0.96
Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol (2002) 0.96
Immunofluorescent method for the detection of antigammaglobulin antibodies. Arthritis Rheum (1973) 0.96
Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma. Int J Oncol (1999) 0.95
Macrophage activation in rat models of inflammation and arthritis: determination of markers of stages of activation. Cell Immunol (1986) 0.95
Normal immunosuppressive protein inhibition of human and murine lymphoblastoid cell line proliferation. Eur J Immunol (1979) 0.95
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees. Clin Immunol (2001) 0.94
Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine (1992) 0.94
Normal immunosuppressive protein purification and quantitative estimation experiments. J Immunol Methods (1979) 0.93
A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation. J Immunol (1998) 0.93
Tracheal intubation using alfentanil and no muscle relaxant: is the choice of hypnotic important? Anesth Analg (1997) 0.93
Autoregulation of spinal cord blood flow: is the cord a microcosm of the brain? Stroke (1987) 0.92
Cooperative effects in antibody formation produced by hapten-specific delayed sensitivity. J Immunol (1973) 0.92
Long-term survival after prehospital cardiac arrest: analysis of outcome during an 8 year study. Circulation (1984) 0.91
Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochim Biophys Acta (1990) 0.91
Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arthritis Rheum (1988) 0.91
Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc Natl Acad Sci U S A (1992) 0.90
Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability. Clin Genet (2013) 0.90
Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation. J Clin Oncol (1994) 0.89
Nasopharyngeal Streptococcus pneumoniae among under-five year old children at the Moi Teaching and Referral Hospital, Eldoret, Kenya. East Afr Med J (2007) 0.89
Evaluation of the Phadebact ETEC-LT test for the heat-labile enterotoxin of Escherichia coli. Zentralbl Bakteriol (1989) 0.89
Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002. Int J Immunopharmacol (1988) 0.89
Lack of platelet effect with the aspirin analog, salsalate. Arthritis Rheum (1980) 0.89
Effect of Normal Immunosuppressive Protein (NIP) on tumor growth in mice. Eur J Cancer (1975) 0.88
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol (2005) 0.88
Role of normal immunosuppressive protein (NIP) in immunologic surveillance. Transplant Proc (1977) 0.87